PATENT CLAIM ANALYSIS

Application Number: 15751802
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "04400A"]

Abstract:
The present disclosure generally relates to methods for treating, preventing, inhibiting the progression of or reducing the likelihood of occurrence of a myocardial infarction-related complication, a cardiac disorder characterised by abnormal conduction and other cardiac conditions. The present disclosure also generally relates to one or more inhibitors of Connexin 45.

Claim (Index 12):
The method of  claim 1 , wherein the inhibitor of Cx45 is administered in an amount effective to reduce or inhibit the prolongation of QRS interval and/or PR interval in the subject.

Metadata:
- Claim Count in Document: 54.0
- Percentile: 88.0
- Lexical Diversity: 1.41026
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14357195', '15813469', '12811306', '12960313', '09376317']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7781208392713334
- 35 USC 102 Novelty (BERT): 0.5223726443190495
- Combined Prediction Score: 0.7525460197761049
- Mean Citation Score: 238.179764
- Max Citation Score: 248.25278
- Similarity Product: 125.49910943095922

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test